PT MSIG Life Insurance Indonesia Tbk (ISX:LIFE) Net Change in Cash : Rp-193,254 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is PT MSIG Life Insurance Indonesia Tbk Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

PT MSIG Life Insurance Indonesia Tbk's Net Change in Cash for the three months ended in Mar. 2024 was Rp-85,898 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was Rp-193,254 Mil.

PT MSIG Life Insurance Indonesia Tbk Net Change in Cash Historical Data

The historical data trend for PT MSIG Life Insurance Indonesia Tbk's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT MSIG Life Insurance Indonesia Tbk Net Change in Cash Chart

PT MSIG Life Insurance Indonesia Tbk Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-62,713.00

143,561.00

707,469.00

-165,554.00

-584,791.00

PT MSIG Life Insurance Indonesia Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-477,435.00	-100,704.00	87,418.00	-94,070.00	-85,898.00

PT MSIG Life Insurance Indonesia Tbk Net Change in Cash Calculation

PT MSIG Life Insurance Indonesia Tbk's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-875047	+	674417	+	-382441	+	-1720
	=	-584,791

PT MSIG Life Insurance Indonesia Tbk's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -345833 + 260349 + -2476 + 2062

= -85,898

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-193,254 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT MSIG Life Insurance Indonesia Tbk Net Change in Cash Related Terms
Thank you for viewing the detailed overview of PT MSIG Life Insurance Indonesia Tbk's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

PT MSIG Life Insurance Indonesia Tbk (ISX:LIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » PT MSIG Life Insurance Indonesia Tbk (ISX:LIFE) » Definitions » Net Change in Cash

Comparable Companies

ISX:APIC ISX:PNLF ISX:PNIN ISX:BHAT ISX:JMAS ISX:CASA SHSE:601628 SHSE:601318 HKSE:01299 BOM:543526 AFL MET PRU SHSE:601601 TSX:MFC LSE:PRU TSX:GWO TPE:2881 TSE:8750 TPE:2882

Traded in Other Exchanges

N/A

Address

Jalan Mangga Dua Raya, Wisma Eka Jiwa, 8th-9th Floor, Jakarta Pusat, Jakarta, IDN, 10730

Website

https://www.sinarmasmsiglife.co.id

PT MSIG Life Insurance Indonesia Tbk Formerly PT Asuransi Jiwa Sinarmas MSIG Tbk is involved in the life insurance business. The company's products are diversified into six categories namely Term life insurance, Endowment, Whole life insurance, Health insurance, Personal accident insurance, and Unit link Insurance.

PT MSIG Life Insurance Indonesia Tbk (ISX:LIFE) Headlines

From GuruFocus

aTyr Pharma Announces Third Quarter 2022 Results and Provides Corporate Update
By Value_Insider Value_Insider • 11-10-2022

aTyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd.
By Stock market mentor Stock market mentor • 02-06-2023

aTyr Pharma Announces LTBP1 as Target of DARS tRNA Synthetase Fragment
By Value_Insider Value_Insider • 12-15-2022

aTyr Pharma Gains E.U. Patent Covering Use of Efzofitimod with Pirfenidone for Lung Inflammation or Fibrosis
By Stock market mentor Stock market mentor • 01-19-2023

aTyr Pharma to Present on Lead Therapeutic Candidate Efzofitimod at the World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) Conference
By sperokesalga sperokesalga • 06-20-2023

aTyr Pharma Announces Pricing of Public Offering of Common Stock
By sperokesalga sperokesalga • 02-09-2023

aTyr Pharma Presents New Data on Efzofitimod Mechanism of Action and Positive Exposure-Response at the American Thoracic Society 2023 International Conference
By sperokesalga sperokesalga • 05-22-2023

aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
By Marketwired • 08-09-2023

aTyr Pharma Announces Publication of Positive Data from Phase 1b/2a Clinical Study of Efzofitimod for the Treatment of Pulmonary Sarcoidosis in the Journal CHEST
By Value_Insider Value_Insider • 11-09-2022

aTyr Pharma to Present New Data on the Mechanism of Action of Efzofitimod at the American Thoracic Society 2023 International Conference
By Stock market mentor Stock market mentor • 01-31-2023